Comparison of Subcutaneous Versus Intravenous Filgrastim in Autologous Hematopoietic Stem Cell Transplantation: A Retrospective Study
In patients with myeloma undergoing autoHSCT, no differences in time to neutrophil recovery, incidence of or duration of gram-negative antibiotic treatment, or 30-day mortality were observed between IVPB and SQ routes of filgrastim administration.
Authors
- Glenn Chang (ORCID: https://orcid.org/0000-0003-4008-1725)
- Doreen Pon (ORCID: https://orcid.org/0000-0002-2751-2597)
- Justin H. Nguyen (ORCID: https://orcid.org/0000-0002-5520-3273)
- Edith M. Sampson (ORCID: https://orcid.org/0000-0002-2891-6630)
Institutions
- City Of Hope National Medical Center (US)
- Western University of Health Sciences (US)
Publication Details
- Journal
- Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy
- Published
- 2025-11-01
- DOI
- https://doi.org/10.1002/phar.70067
- Primary Topic
- Neutropenia and Cancer Infections
- Type
- article
- Field-Weighted Citation Impact
- 0.00